These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. Lambotte O; Gelu-Simeon M; Maigne G; Kotb R; Buffet C; Delfraissy JF; Goujard C J Infect; 2005 Oct; 51(3):e113-5. PubMed ID: 16230187 [TBL] [Abstract][Full Text] [Related]
17. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon. Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188 [TBL] [Abstract][Full Text] [Related]
18. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha. Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007 [TBL] [Abstract][Full Text] [Related]
19. Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C. Medeiros BC; Seligman PA; Everson GT; Forman LM J Clin Gastroenterol; 2004 Jan; 38(1):84-6. PubMed ID: 14679335 [No Abstract] [Full Text] [Related]